Plasma protein binding affinity and its relationship to molecular structure: an in-silico analysis.
In-silico plasma protein binding (PPB) models have been generated on human and rat in-house datasets, and on a human dataset sourced from the literature. From the results reported herein, it is apparent that models built on datasets relevant to the chemotypes under investigation in lead optimization programs will perform considerably better in this role than those generated on diverse compounds sourced from the literature. The in-house human and rat partial least-squares regression (PLS) models have cross-validated q2 values of 0.53 and 0.42 on the training sets, respectively. On the independent test and validation sets, they display similar predictive ability, with logK prediction errors of approximately 0.5 log units. This compares to approximately 0.25 log units variability expected for experiment. Given the considerable interspecies PPB differences, the prediction of PPB in one species using measurements in the other is no better than a prediction from an in-silico model generated on that species.
Gleeson
M Paul
MP
Computational, Analytical & Structural Sciences, GlaxoSmithKline Medicines Research Centre, Stevenage, Hertfordshire, SG1 2NY, United Kingdom. paul.x.gleeson@gsk.com
D000704:Analysis of Variance; D000818:Animals; D001798:Blood Proteins / Q000378:metabolism*; D016208:Databases, Factual; D006801:Humans; D008954:Models, Biological; D015394:Molecular Structure; D004364:Pharmaceutical Preparations / Q000737:chemistry / Q000378:metabolism*; D011485:Protein Binding; D021281:Quantitative Structure-Activity Relationship; D051381:Rats
D001798:Blood Proteins; D004364:Pharmaceutical Preparations